Package 70095-130-01

{"route": ["INTRAVENOUS"], "spl_id": "32956dbc-6fe7-4e40-8496-cead92e453b7", "openfda": {"nui": ["N0000193338", "N0000193337", "N0000193336", "M0001357"], "unii": ["PNW7GBB44P"], "rxcui": ["2717518", "2717525"], "spl_set_id": ["06bdadd5-d2db-406f-a3f8-de47f48a52e3"], "pharm_class_cs": ["Antibodies, Monoclonal [CS]"], "pharm_class_epc": ["Programmed Death Ligand-1 Blocker [EPC]"], "pharm_class_moa": ["Programmed Death Ligand-1 Antagonists [MoA]", "Programmed Death Ligand-1-directed Antibody Interactions [MoA]"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, GLASS in 1 CARTON (70095-130-01)  / 5 mL in 1 VIAL, GLASS", "package_ndc": "70095-130-01", "marketing_start_date": "20251208"}], "brand_name": "UNLOXCYT", "product_id": "70095-130_32956dbc-6fe7-4e40-8496-cead92e453b7", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Antibodies", "Monoclonal [CS]", "Programmed Death Ligand-1 Antagonists [MoA]", "Programmed Death Ligand-1 Blocker [EPC]", "Programmed Death Ligand-1-directed Antibody Interactions [MoA]"], "product_ndc": "70095-130", "generic_name": "cosibelimab", "labeler_name": "Sun Pharmaceutical Industries, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "UNLOXCYT", "active_ingredients": [{"name": "COSIBELIMAB", "strength": "300 mg/5mL"}], "application_number": "BLA761297", "marketing_category": "BLA", "marketing_start_date": "20251208", "listing_expiration_date": "20261231"}